Alzheimer's Disease Data Initiative

What Alzheimer's Disease Data Initiative does

Alzheimer's Disease Data Initiative (ADDI) is a nonprofit research organization founded in 2020 and headquartered in Kirkland, Washington, that builds and operates data infrastructure for the global Alzheimer's and neurodegeneration research community. Its flagship product, the AD Workbench, is a cloud-based platform for sharing, harmonizing, and analyzing datasets across institutional and national boundaries, complemented by the AD Curation Studio for data preparation, the AD Discovery Portal for dataset discovery, FDSA-based federated data sharing, NIH-supported repository services, Workspaces, and the NeuroToolkit (NTK) app. The platform serves academic researchers, clinicians, pharmaceutical R&D teams, and patient-advocacy organizations, with 10,000+ registered users across 129+ countries and a catalog of 340+ datasets encompassing 850K+ participant records.

The platform's data footprint has been deliberately broadened beyond clinical and genomic data into proteomics via the Global Neurodegeneration Proteomics Consortium (GNPC) v1, which contributes 250M+ protein measurements, positioning ADDI as a multimodal research backbone rather than a single-modality repository. The organization has also begun productizing AI workflows, including the Alzheimer's Insights AI Prize ($2M) targeting agentic AI applications and the William H. Gates Sr. Fellowship Cohort II focused on generative AI. Partnerships with Vivli (clinical trial data), IGC Pharma, and other industry stakeholders indicate an evolving role as the connective tissue between pharma R&D, trial data, and academic science.

ADDI operates as a nonprofit and does not charge users for access. Its operating budget is sustained by a coalition of funders including Bill Gates / Gates Ventures, the NIH, the Alzheimer's Association, and a group of major pharmaceutical companies. With 11–50 employees and a multi-stakeholder governance structure, the organization is positioned as a public-good data utility rather than a commercial vendor, with strategic decisions driven by coalition priorities and scientific impact rather than revenue growth.

Name

Alzheimer's Disease Data Initiative

Legal name

Alzheimer's Disease Data Initiative, Inc.

Website

https://alzheimersdata.org

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

11–50 employees

Short description

Alzheimer's Disease Data Initiative is a nonprofit founded in 2020 that operates the AD Workbench, a cloud platform enabling global researchers to share and analyze 340+ Alzheimer's and neurodegeneration datasets across 129+ countries, funded by a Gates/NIH/pharma coalition.

Ownership category

akta.pro rank

Product category

Biomedical Research Data Platform

NAICS

Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (5182), Web Search Portals, Libraries, Archives, and Other Information Services (519)

SIC

Services-Computer Processing & Data Preparation (7374), Services-Computer Programming, Data Processing, Etc. (7370)

akta.pro primary industry

Patient-Mediated Exchange & Personal Health Data Access (Blue Button, SMART on FHIR) (HLACABAN)

akta.pro secondary industry

Electronic Data Capture (EDC) Platforms (HLACAOAA)

Keywords

• Biomedical research data
• Clinical data sharing
• Alzheimer's research platform
• Federated data analytics
• Scientific data collaboration

Headquarters

HQ city

Kirkland

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales

Revenue model

1. Coalition/Funder Support: AD Data Initiative is a non-profit coalition funded by leading academic, governmental, philanthropic, and industry organizations. The initiative operates at no cost to researchers, with all products and services provided free of charge.

Pricing tiers

Go-to-market motion4 records

Distribution channels3 records

Marketing channels6 records

Core offering

Alzheimer's Disease Data Initiative operates AD Workbench, a secure, cloud-based data sharing and analytics platform that serves as an interoperability layer connecting multiple Alzheimer's disease and related dementias (ADRD) data platforms. It provides researchers worldwide with free access to 340+ datasets, 850K+ participant records, collaborative workspaces, and a suite of tools for data curation, federated sharing, and multimodal analysis. The initiative is funded by a global coalition of academic, industry, government, and nonprofit partners and offers all products and services at no cost to users.

Product overview

The Alzheimer's Disease Data Initiative operates a comprehensive product suite designed to transform Alzheimer's disease and related dementias (ADRD) research through data sharing. The flagship product is AD Workbench, a secure, cloud-based data sharing and analytics environment serving as the interoperability layer for the technical suite. Supporting modules include: AD Curation Studio for data preparation and anonymization; the AD Data Initiative Repository as an NIH-supported domain-specific data repository; and the Federated and Distributed Data Sharing Appliance (FDSA) for secure remote data sharing. The ecosystem includes the AD Discovery Portal for dataset exploration, Workspaces for collaborative analysis, and the NeuroToolkit (NTK) for specialized analytics. Strategic initiatives include the $1M Alzheimer's Insights AI Prize for agentic AI solutions and the William Gates Sr. Fellowship program. The platform hosts 340+ datasets, 10K+ registered users from 129+ countries, and powers major research efforts including the Global Neurodegeneration Proteomics Consortium (GNPC) and SpeechDx digital biomarker studies.

Differentiator

Problem solved

Functional benefit

Brands

• AD Workbench: Secure, cloud-based data sharing and analytics environment that serves as the interoperability layer of the AD Data Initiative technical suite; provides 340+ datasets, 850K+ participant records, 10K+ registered users from 129+ countries at no cost to users.
• AD Curation Studio
• AD Data Initiative Repository
• Federated and Distributed Data Sharing Appliance (FDSA)
• AD Discovery Portal

Products and services

• AD Workbench Secure, cloud-based data sharing and analytics environment that serves as the interoperability layer connecting multiple data sharing platforms (Answer ALS, DPUK, GAAIN, Vivli, EPND, HDR UK). Provides 340+ datasets, 850K+ participant records, collaborative workspaces, computational models, and in-platform analytical tools for Alzheimer's and dementia researchers worldwide. ISO/IEC 27001, GDPR, and HIPAA-compliant.
• AD Curation Studio Suite of tools designed to help researchers prepare, anonymize, and harmonize data from international clinical trials and biomedical research before making it discoverable via AD Workbench. Access limited to authorized users and accommodates PHI and PII data with secure audit trails.
• AD Data Initiative Repository

Quantifiable outcome

• 340+ datasets available from leading institutions
• +3 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration8 records

AI capability9 records

Feature6 records

Partnerships

20 partnerships are on record, tiered core, key, founding, supporting and emerging.

• GRIP (Global Research Platforms, LLC)coreTechnology or Integration · 1 January 2020GRIP platform is the core technology powering AD Workbench. It is a community-driven platform enabling interoperability, collaboration, and data analytics. GRIP is an ISO/IEC 27001, GDPR, and HIPAA-compliant platform and is a wholly-owned subsidiary of AD Data Initiative, Inc.
• AridhiacoreTechnology or Integration · 1 January 2020Aridhia DRE (Data Research Environment) powers secure analyses and AD Workbench Workspaces. Provides the infrastructure for collaborative, secure data analysis environments.
• Dementias Platform UK (DPUK)keyTechnology or IntegrationData platform partnership to ensure interoperability with DPUK data sharing platform, expanding cross-platform dataset access for researchers.
• Global Alzheimer's Association Interactive Network (GAAIN)keyTechnology or IntegrationData platform partnership enabling interoperability with GAAIN's Alzheimer's research data network.
• VivlikeyTechnology or IntegrationData platform partnership with Vivli for clinical trial data sharing and interoperability.
• European Platform for Neurodegenerative Diseases (EPND)keyTechnology or IntegrationPartnership with EPND to ensure interoperability and expand access to European neurodegenerative disease data.
• Health Data Research UK (HDR UK)keyTechnology or IntegrationPartnership with HDR UK for data platform interoperability and UK research community engagement.
• Answer ALSkeyTechnology or IntegrationData platform partnership with Answer ALS for ALS/neurodegeneration data interoperability.
• Alzheimer's AssociationfoundingStrategic or Co-development PartnerMajor coalition partner providing scientific expertise, AAIC conference collaboration, and research community connections.
• Alzheimer's Research UKkeyStrategic or Co-development PartnerUK-based coalition partner supporting data challenges and research collaboration in Europe.
• Eli Lilly and CompanykeyStrategic or Co-development PartnerPharmaceutical coalition partner contributing data, expertise, and supporting initiatives like the Alzheimer's Trials Data Discovery Challenge.
• Johnson & Johnson Innovative MedicinekeyStrategic or Co-development PartnerPharmaceutical coalition partner providing research data and scientific expertise to the initiative.
• EisaikeyStrategic or Co-development PartnerPharmaceutical coalition partner contributing to data sharing and research collaboration efforts.
• UKRI Medical Research CouncilkeyStrategic or Co-development PartnerUK government research funding body as coalition partner supporting dementia research data sharing.
• WellcomekeyStrategic or Co-development PartnerGlobal charitable foundation funding health research as coalition partner.
• AARPsupportingStrategic or Co-development PartnerCoalition partner focused on brain health and aging research advocacy.
• UW MedicinekeyStrategic or Co-development PartnerAcademic medical center partner providing research expertise and institutional backing.
• World Health Organization (WHO)supportingStrategic or Co-development PartnerWHO participates as coalition advisor on neurological disorders and global health policy.
• Alzheimer's Drug Discovery Foundation (ADDF) - Diagnostics AcceleratorkeyStrategic or Co-development PartnerADDF's Diagnostics Accelerator convened the SpeechDx project, which uses AD Curation Studio to harmonize digital speech and clinical data for early Alzheimer's diagnosis research.
• IGC PharmaemergingStrategic or Co-development PartnerCollaboration to demonstrate IGC Pharma's Agentic Harmonization Assistant (AHA) AI platform alongside AD Data Initiative at ADPD 2026 conference, exploring integration with AD Workbench.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• EBRAINS: European-funded neuroscience research infrastructure providing data sharing, analysis, and modeling services for brain research. Comparable as a federated neuroscience data platform serving academic researchers across institutions.
• Vivli: Clinical trial data sharing platform and ADDI partner that enables sharing and analysis of participant-level clinical trial data. Directly comparable as a research data sharing and analytics platform, with overlap in pharma data hosting and cross-trial analysis.
• Sage Bionetworks (Synapse): Open-source data sharing and analysis platform (Synapse) widely used in biomedical and neurodegeneration research. Directly comparable as a hosted research data commons with collaborative workspaces and analysis tools.
• Global Alzheimer's Association Interactive Network (GAAIN): Alzheimer's Association-led federated data network of Alzheimer's research cohorts worldwide. ADDI partner with overlapping mission of federated AD data discovery and analysis for global researchers.
• Dementias Platform UK (DPUK): UK-based dementia data sharing platform and ADDI partner offering cohort data and analytics tools to dementia researchers. Directly comparable in mission, customer base (dementia researchers), and interoperability ambitions.
• Answer ALS: Large-scale ALS data generation and sharing program with integrated cell lines, multi-omics, and clinical data. ADDI partner with overlapping mission of open, harmonized neurodegeneration data for researchers.
• European Platform for Neurodegenerative Diseases (EPND): European neurodegenerative disease data sharing platform and ADDI partner. Closely comparable as a multi-cohort, multi-disease data platform serving academic and industry neurodegeneration researchers.

Regional players

• Health Data Research UK (HDR UK): UK national institute for health data science coordinating datasets and analytics for population and clinical health research. ADDI partner; comparable in interoperability and coalition-building, but oriented to UK health data rather than AD-specific research.

Emerging players

• Observational Health Data Sciences and Informatics (OHDSI): International collaborative generating large-scale observational health data analytics using a common data model. Comparable in enabling federated, large-scale health data analytics, though focused more on clinical populations than AD-specific research.

Others

• Aridhia: Data Research Environment (DRE) provider whose technology powers AD Workbench workspaces. Adjacent technology vendor enabling secure biomedical analytics environments, more partner than competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/alzheimersdata
• Xx.com/AlzData

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Alzheimer's Disease Data Initiative